ANAPTYSBIO, INC
For the period ended Mar 31, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 12, 2026
ANAB$46.45+1.9%Stored close · as of Nov 6, 2026
Contents
Item 1. Consolidated Financial Statements (unaudited)
Item 1. Consolidated Financial Statements
Anaptys Bio, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.